← All organizations
Highest phase reached
Phase 2
First clinical trial
Oct 1, 2007Last known activity
Nov 22, 2022
Timeline
1980s
- Jul 1, 1984
Nordic MDS Group— Founded
Drugs by trial phase (6 distinct, 6 trials)
Phase 2 (5 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Recent trials (10)
- NCT05788679CollaboratorPhase 2Nov 22, 2022
- NCT03040401CollaboratorPhase 1/Phase 2Feb 15, 2017
- NCT01556477Lead sponsorPhase 2Mar 1, 2012
- NCT01556477Overall official - principal investigatorPhase 2Mar 1, 2012
- NCT01481220Study directorPhase 1Oct 1, 2011
- NCT01481220Lead sponsorPhase 1Oct 1, 2011
- NCT01048034Lead sponsorPhase 2Jan 1, 2010
- NCT01048034Study directorPhase 2Jan 1, 2010
- NCT00761449Lead sponsorPhase 2Oct 1, 2007
- NCT00761449Overall official - principal investigatorPhase 2Oct 1, 2007
Details
- Founded
- Stockholm, SE Jul 1, 1984
- Last known activity
- Nov 22, 2022